(Q38903138)

English

Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

cholangiocarcinoma

0 references

author name string

Qing-Xin Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Xing-Ming Jiang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Zhi-Dong Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Chun-Long Li

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yun-Fu Cui

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

6 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Pathogenesis, diagnosis, and management of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

The basics of epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Cholangiocarcinoma: Current concepts and insights

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Serum and bile markers for cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Inflammation and cancer: IL-6 and STAT3 complete the link.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

SOCS, inflammation, and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

SOCS regulation of the JAK/STAT signalling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

IL-6/STAT3/TFF3 signaling regulates human biliary epithelial cell migration and wound healing in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Cancer-related inflammation and treatment effectiveness

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0553-7

21 January 2018

Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/25744243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current therapy of hilar cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25744243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25744243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/25744243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-015-0553-7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38903138&oldid=2202267816"